Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced influenza vaccination schedule in children with cancer
ACTRN12620000548932Phase 4Completed
- Sponsor
- Center for Applied Health Sciences
- Start
- May 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Vaxigrip in influenza (2 arms), sponsored by Center for Applied Health Sciences. Primary endpoints: Influenza-specific hemagglutinin inhibition antibody response, Cellular immune response by IFN-gamma ELISpot and 1 more. Started May 2020; status: completed.
02
Drugs
Vaxigrip
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12620000548932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000548932.